Infectious Disease
RSSArticles
-
Reynolds Risk Score: An Update to Cardiovascular Risk Assessment in Women
For women, up to 20% of all coronary events occur in the absence of traditional major risk factors, and many women with these risk factors do not develop coronary events. -
Full May 15, 2007 Issue in PDF
-
Pharmacology Watch
Torcetrapib, a cholesteryl ester transfer protein (CETP) inhibitor, has been in development by Pfizer for nearly 15 years. -
Clinical Briefs By Louis Kuritzky, MD
Persons who do not suffer hyperhidrosis (HID) may be surprised to learn that it has been associated with both occupational and physical impairment, as well as limitations in social interaction. -
Vorinostat Capsules (Zolinza™)
A new class of drug has been approved for the treatment of cutaneous T-cell lymphoma (CTCL) such as mycosis fungoides. -
Score One for the Kidneys
A simple questionnaire can identify individuals at risk for chronic kidney disease. -
Full May 2007 Issue in PDF
-
Clinical Briefs in Primary Care supplement
-
Pharmacology Watch: Long-Awaited Torcetrapib Will Not Be Released, Too Risky
IBS-Drug Treatment Pulled, CV Side Effects; Drug Combo Better for Migraine Treatment; Pergolide Off the Market, Heart Disease Risk; Hormone Treatment, Does Timing Matter?; FDA Actions -
Updates By Carol A. Kemper, MD, FACP
Quinolone-Resistant Neisseria Gonorrhea (QRNG) continues to spread with alarming frequency across the United States.